Healthcare AI investors focused on Pharma / Therapeutics

Venture firms, family offices, accelerators, and corporate VCs with explicit thesis exposure to Pharma / Therapeutics within healthcare AI. Includes lead investors, follow-on participants, and active angels.

The therapeutics sector focuses on the scientific research, clinical development, and commercialization of chemical or biological compounds used to treat diseases. Venture investment in this space is heavily milestone-driven, guiding novel drugs from early pre-clinical laboratory research through rigorous, multi-phase human clinical trials to ultimate regulatory approval.
344 investors match

Within Pharma / Therapeutics: top investment stages

Series A (239) Seed (236) Series B (163) Growth (144) Pre-Seed (105) Series C (89) Series D+ (38) Post-IPO (2)
Insight Partners
Solo Angel T1
New York, Israel
<$250k
Insight Partners is a New York-based growth-equity firm that has, over the last decade, become one of the largest and most-active software…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
Integra Holdings
VC T3
Jerusalem, Israel
$1M-$5M
Integra Holdings is a Jerusalem-based investment vehicle operating closely with Hebrew University of Jerusalem, structured to translate the institution’s life sciences research…
Biotech Medical Devices / MedTech
InterWest Partners
VC T3
San Francisco, United States
InterWest Partners is a long-running Menlo Park-based venture firm with roughly four decades of history investing in healthcare and technology, with a…
Biotech Digital Health
Invus
Family Office T3
New York, United States
$25M+
Invus is a New York-based long-horizon investment firm with origins as the family office of the Belgian Frere family, deploying patient capital…
AI/ML in Healthcare Biotech
IQ Capital
VC T3
London, United Kingdom
$1M-$5M
IQ Capital is a Cambridge, UK-based deep tech venture firm investing in early-stage technical companies across AI, machine learning, quantum, and computational…
AI/ML in Healthcare Biotech
IrishAngels
Angel Network T3
Chicago, United States
$250k-$1M
IrishAngels is a Notre Dame-affiliated angel investment network rather than a traditional venture fund, comprised of alumni and friends of the University…
Care Delivery / Tech-Enabled Services Diagnostics
Isomorphic Labs
Corporate VC T3
London, United Kingdom
Isomorphic Labs is not a venture investor; it is an Alphabet-owned drug discovery company spun out of DeepMind in 2021 to apply…
AI/ML in Healthcare Biotech
Israel Biotech Fund (IBF)
VC T3
Rehovot, Israel
$5M-$25M
Israel Biotech Fund, IBF for short, is a specialized life sciences investor based in Rehovot that allocates exclusively to drug development and…
Biotech Pharma / Therapeutics
Iter Investments
VC T3
Fort Lauderdale, United States
$1M-$5M
Iter Investments is a Fort Lauderdale venture firm deploying capital into early-stage companies advancing the psychedelic medicine and mental healthcare ecosystem. The…
Mental & Behavioral Health Pharma / Therapeutics
Jaza Rift Ventures
VC T3
Nairobi, Kenya
$250k-$1M
Jaza Rift Ventures is an Africa-focused early-stage venture fund investing in technology companies across the continent, with a thesis built around emerging…
AI/ML in Healthcare Biotech
Jefferies
PE T3
New York, United States
Jefferies is a global investment bank rather than a venture fund, with healthcare exposure primarily through its equity capital markets, M&A, and…
Biotech Care Delivery / Tech-Enabled Services
Jeito Capital
VC T3
Paris, France
$25M+
Jeito Capital is a Paris-based independent investment firm deploying significant global capital to accelerate the clinical development of life-saving therapeutics. The firm…
Biotech Pharma / Therapeutics
JLS Fund
VC T3
New York, United States
$250k-$1M
JLS Fund is a New York investment firm backing early-stage biopharmaceutical companies focused on novel neuro-therapeutics and psychedelic medicines. The combined mandate…
Mental & Behavioral Health Pharma / Therapeutics
Johnson & Johnson Innovation
Corporate VC T3
New Brunswick, United States
Johnson and Johnson Innovation is the umbrella for J and J’s corporate venture, business development, and incubator activities, including JJDC (Johnson and…
AI/ML in Healthcare Biotech
Kaitai Capital
VC T3
Hangzhou, China
$1M-$5M
Kaitai Capital is a Hangzhou-based early-stage investor specializing in cutting-edge biotechnology therapeutics and novel drug delivery mechanisms, with broader pharma and biotech…
Biotech Pharma / Therapeutics
AI Tool Finder
AI-powered search. Results may not be comprehensive.